Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH-001 in men with lifelong premature ejaculation
NCT07434271Phase 2Recruiting
- Sponsor
- Kadence Bio
- Start
- Dec 2025
- Primary completion
- Oct 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of KH-001 in premature ejaculation (PE), sponsored by Kadence Bio. Started Dec 2025; status: recruiting.
02
Drugs
KH-001
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT07434271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07434271.